ÂÜÀòÂÒÂ×

Tyler Molitor is a seasoned professional in the field of pharmacology and drug discovery, currently serving as Director of In Vivo Pharmacology at Neuron23 since August 2022, where the focus is on utilizing AI-driven models for precision medicine. Prior experience includes roles at ESCAPE Bio from January 2019 to August 2022, where innovative small molecule treatments for neurodegenerative diseases were developed, and significant contributions at the Parkinson's Institute and Clinical Center from February 2013 to October 2020, overseeing preclinical research and animal model development for Parkinson's disease interventions. Tyler's academic foundation includes a PhD in Molecular Genetics from the Medical College of Wisconsin and a BA in Biology from Lawrence University, complemented by early career roles in research and customer service.